New European Centre for Chirality for Advancements in Chiral Chemical Processes

27-Sep-2010 - Belgium

Ghent University, the University of Antwerp and BioTools Europe Ltd announced a new partnership to create the European Centre for chirality (EC2). EC2 is a unique blend of expertise and resources that brings together leading authorities dedicated to advancing the understanding the role chirality plays in biological processes. The EC2 mission is to help academic and industrial scientists develop a broad range of chirality related applications through offering services ranging from the determination of absolute chiral configurations, Vibrational Optical Activity (VOA) measurements, computational modelling including expert consultancy, and education workshops to open access VOA instrumentation. Given the importance of chirality in e.g., drug discovery and development, the information obtained using these techniques can benefit productivity in drug discovery, diagnostics research, drug development and registration. The new Centre, based at Antwerp and Ghent, Belgium, will comprise a team of dedicated scientists, including some of the world’s most respected leaders in VOA, using an array of advanced analytical instrumentation and modelling software able to fulfil the demanding analysis such challenging applications require.

The Centre will open on December 2nd 2010, and to mark this occasion EC2 will hold a day-long scientific programme and show-case BioTools advanced instrumentation.

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Last viewed contents

Novartis announces typhoid vaccine research program in partnership with the Wellcome Trust - New grant from the Wellcome Trust funds progression of vaccine from preclinical through Phase I and II studies with view to protect against both S. Typhi and S. Paratyphi strains

Making sense of what you see in biomedical images - The conventional procedure requires 77 hours, compared to 9 hours with Biomedisa

Making sense of what you see in biomedical images - The conventional procedure requires 77 hours, compared to 9 hours with Biomedisa

Genmab and Seattle Genetics Enter Into Antibody-Drug Conjugate Research Collaboration

Researchers identify neuronal mechanisms that control food cravings during pregnancy - Dopamine and compulsive eating behaviour

Researchers identify neuronal mechanisms that control food cravings during pregnancy - Dopamine and compulsive eating behaviour

Amorfix achieves technical milestone in development of a blood test for Alzheimer's disease

Helén Tuvesson appointed as new Chief Scientific Officer at Active Biotech

Amorfix Life Sciences' test detects scrapie prions in bllod ofg scrapie-infected sheep

Argenta Announces Integrated Drug Discovery Collaboration with Dr. Reddy's Laboratories Ltd

Mice with human antigen presenting molecules demonstrate strong responses to novel melanoma peptide vaccine

Flame retardant ban reduces exposures in pregnant women

Peregrine Enters Contract Negotiations With U.S. DTRA for Hemorrhagic Fevers - U.S. Department of Defense Agency Has Selected Peregrine for a Multi-Year Award That Could Total $44.5 Million Pending Successful Contract Negotiations

Food safety in Europe - who is responsible for what? - BfR publishes 2. completely revised edition of the EU Food Safety Almanac